Search
![](https://static.wixstatic.com/media/nsplsh_6567543378744475394451~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_6567543378744475394451~mv2.jpg)
![USFDA Guidance: Considerations for the Use of Human-and Animal-Derived Materials & Recognition and Use of a Standard for Uniform Blood & Blood Component Container Labels](https://static.wixstatic.com/media/nsplsh_6567543378744475394451~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_6567543378744475394451~mv2.jpg)
Sharan Murugan
- May 1
- 2 min
USFDA Guidance: Considerations for the Use of Human-and Animal-Derived Materials & Recognition and Use of a Standard for Uniform Blood & Blood Component Container Labels
Yesterday (30 April 2024), the FDA released a draft guidance for the industry titled "Considerations for the Use of Human-and...
17 views0 comments
![](https://static.wixstatic.com/media/nsplsh_a98ed4ba5c05420ab03437ddfde1e481~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_a98ed4ba5c05420ab03437ddfde1e481~mv2.jpg)
![Saudi's SFDA: Good Manufacturing Practice for Blood Establishments](https://static.wixstatic.com/media/nsplsh_a98ed4ba5c05420ab03437ddfde1e481~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_a98ed4ba5c05420ab03437ddfde1e481~mv2.jpg)
Sharan Murugan
- Feb 7
- 2 min
Saudi's SFDA: Good Manufacturing Practice for Blood Establishments
Blood establishments play a crucial role in ensuring a safe and adequate supply of blood for transfusion and other medical purposes. To...
28 views0 comments
![](https://static.wixstatic.com/media/nsplsh_60e44b0f66414cf5a7ca0f4dde31133d~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_60e44b0f66414cf5a7ca0f4dde31133d~mv2.jpg)
![USFDA Guidance: Policy for Testing of Alcohol & Developing Drugs for DFI Treatment](https://static.wixstatic.com/media/nsplsh_60e44b0f66414cf5a7ca0f4dde31133d~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_60e44b0f66414cf5a7ca0f4dde31133d~mv2.jpg)
Sharan Murugan
- Oct 17, 2023
- 2 min
USFDA Guidance: Policy for Testing of Alcohol & Developing Drugs for DFI Treatment
Earlier today (17 October 2023) the United States Food & Drug Administration's Center for Drug Evaluation and Research and Center for...
15 views0 comments
![](https://static.wixstatic.com/media/nsplsh_8a1786f026464a9bbc57703ac7e7e327~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_8a1786f026464a9bbc57703ac7e7e327~mv2.jpg)
![USFDA Guidance: Testing of Glycerin & High Risk Drug Components & CBER Guidances on Blood Products](https://static.wixstatic.com/media/nsplsh_8a1786f026464a9bbc57703ac7e7e327~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_8a1786f026464a9bbc57703ac7e7e327~mv2.jpg)
Sharan Murugan
- May 13, 2023
- 1 min
USFDA Guidance: Testing of Glycerin & High Risk Drug Components & CBER Guidances on Blood Products
This week (11 & 12 May 2023) the United States Food & Drug Administration's Center for Drug Evaluation and Research and Center for...
46 views0 comments
![](https://static.wixstatic.com/media/nsplsh_614d6d444973646e55726f~mv2_d_5184_3456_s_4_2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_614d6d444973646e55726f~mv2_d_5184_3456_s_4_2.jpg)
![USFDA's recent Guidance on Biologics: Ophthalmic Products & Development of (CAR) T Cell Products](https://static.wixstatic.com/media/nsplsh_614d6d444973646e55726f~mv2_d_5184_3456_s_4_2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_614d6d444973646e55726f~mv2_d_5184_3456_s_4_2.jpg)
Sharan Murugan
- Mar 24, 2022
- 1 min
USFDA's recent Guidance on Biologics: Ophthalmic Products & Development of (CAR) T Cell Products
1. Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR This guidance is intended to provide information to applicants...
18 views0 comments